Document Detail

Vascular endothelial growth factor (VEGF), prostaglandin E2(PGE2) and active renin in hypertension of adrenal origin.
MedLine Citation:
PMID:  15636427     Owner:  NLM     Status:  MEDLINE    
There are limited data regarding the role of vascular endothelial growth factor (VEGF) in arterial hypertension. The aim of the present study was to determine some markers of vascular function, including VEGF, active renin and prostaglandin E2 (PGE2) in patients with endocrine hypertension. The study comprised: 30 patients with primary aldosteronism; 32 patients with active Cushing's syndrome; 19 patients with pheochromocytoma; 22 patients with essential hypertension and 24 healthy volunteers. VEGF was significantly elevated in all groups of patients as compared to the controls. VEGF levels in patients with Cushing's syndrome were significantly higher than those in patients with essential hypertension and primary aldosteronism. We did not find significant differences in VEGF levels between patients with Conn adenomas and idiopathic aldosteronism as well as between patients with Cushing's disease and Cushing's syndrome. PGE2 levels were not significantly different among the groups. Active renin was significantly the lowest in patients with primary aldosteronism and significantly the highest in those with pheochromocytoma compared to controls. The level of active renin in patients with primary aldosteronism was significantly lower than in patients with Cushing's syndrome and pheochromocytoma. In conclusion, VEGF levels were significantly elevated in patients with endocrine hypertension due to glucocorticoid, mineralocorticoid and/or catecholamine excess. The highest VEGF levels were detected in patients with Cushing's syndrome. The latter is associated with accelerated development of atherosclerosis and increased cardiovascular risk. VEGF might contribute to the cardiovascular risk in this disease. This effect was not likely to be PGE2 mediated.
S Zacharieva; I Atanassova; M Orbetzova; G Kirilov; E Nachev; K Kalinov; R Shigarminova
Related Documents :
23105497 - Lipid peroxide levels and antioxidant status in alcoholic liver disease.
18423497 - Use of microcirculatory parameters to evaluate clinical treatments of chronic venous di...
10166447 - First trial of home ecg and blood pressure telemonitoring system in macau.
7322327 - Intracranial pressure monitoring in severe pediatric near-drowning.
20383727 - Combined thrombophilic factors increase the risk of recurrent thrombotic events in behc...
20510657 - Report of two patients with associated conditions in addition to cystic fibrosis.
Publication Detail:
Type:  Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of endocrinological investigation     Volume:  27     ISSN:  0391-4097     ISO Abbreviation:  J. Endocrinol. Invest.     Publication Date:  2004 Sep 
Date Detail:
Created Date:  2005-01-07     Completed Date:  2005-04-19     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7806594     Medline TA:  J Endocrinol Invest     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  742-6     Citation Subset:  IM    
Clinical Center of Endocrinology and Gerontology, Medical University, Sofia, Bulgaria.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adrenal Gland Diseases / blood*,  complications*
Biological Markers
Blood Vessels / physiology
Cushing Syndrome / blood,  complications
Dinoprostone / blood*
Hyperaldosteronism / blood,  complications
Hypertension / blood*,  etiology*
Middle Aged
Pheochromocytoma / blood,  complications
Renin / blood*
Vascular Endothelial Growth Factor A / blood*
Reg. No./Substance:
0/Biological Markers; 0/Vascular Endothelial Growth Factor A; 363-24-6/Dinoprostone; EC

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effects of dehydroepiandrosterone (DHEA) supplementation on hormonal, metabolic and behavioral statu...
Next Document:  Effect of single doses of dexamethasone and adrenocorticotrop hormone on serum bone markers in healt...